News

Happy Friday. Today, we talk about the stem cell fire sale at CIRM, and about the FDA’s move to release a limited batch of ...
On this week's episode of "The Readout LOUD": a closer look at the NIH’s grant-cutting legal playbook, FDA transparency ...
The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency. | ...
The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...
The US Food and Drug Administration has started making rejection letters that pharmaceutical companies traditionally keep ...
Beyond staff cuts, the departures of some longtime investigators in recent months have left less experienced people tasked ...
As AI becomes central, the ability to ask the right question isn’t just a technical skill but a foundational one.
A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...
Unlike Drs. Adam Cifu and John Mandrola, I do not constantly boast of my "nuance" or claim to be a master of "clinical ...
In a quiet corner of Glasgow’s East End, a radical public health experiment is underway. For the first time in the United Kingdom, people who inject illicit drugs such as heroin and cocaine can do so ...
An FDA-funded clinical trial found even modest CBD use triggered elevated liver enzymes in some healthy adults, raising ...
While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers about the FDA's new national priority voucher program, experts told ...